Outcom of Board Meeting held on October 14, 2026 to discuss agenda for acquition of Plant at Dahej, SEZ

Date: October 14, 2026 BSE Limited National Stock Exchange of India Limited The Corporate Relations Department, Exchange Plaza, 25th Floor, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (East), Dalal Street, Mumbai - 400 001 Mumbai 400 051 Stock Code – 544187 Stock Code – KRONOX Subject: Outcome of Board Meeting held on October 14, 2026 under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to Regulation 30 read with Schedule III, Part A, Para A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), we would like to inform you that the Board of Directors of the Company, at its meeting held today, i.e., Wednesday, October 14, 2026 has inter alia considered and approved the following: Acquisition of a Plant admeasuring about 5000 Sq. meters located in a Dahej Special Economic Zone from Axiom Chemicals Private Limited The details required under Regulation 30 of the Listing Regulations read with the SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are given in Annexure A. Kindly take the above on record. Thanking you, Yours faithfully, For KRONOX LAB SCIENCES LIMITED Nikhil Goswami Company Secretary Membership No.: A68272 Annexure A: Details of Acquisition Particulars Details Acquisition of Plant admeasuring about 5000 Sq. meters of Axiom Chemicals a Name of the target entity. Private Limited (“Seller”), located at Z/80, Dahej SEZ only and the seller company is not being acquired. Whether the acquisition would fall within related party transaction(s) and whether the No. The Seller is not a related party of the promoter/promoter group/group companies Company, and no promoter/promoter have any interest in the entity being acquired? If group/group company has any interest in yes, nature of interest and details thereof and the Seller or the transaction. whether the same is done at “arm’s length” Industry to which the entity being acquired c Chemicals belongs Objects and impact of acquisition (including but not limited to, disclosure of reasons for The acquisition is to expand d acquisition of target entity, if its business is manufacturing capacity for growth of outside the main line of business of the listed Business. entity) Approval of the Development Commissioner / SEZ authority for transfer Brief details of any governmental or regulatory of unit/land lease rights, other approvals, approvals required for the acquisition e.g., State Pollution Control Board, GIDC / relevant other development authority consent], as applicable. Within one month, subject to receipt of Indicative time period for completion of the F requisite approvals and execution of acquisition definitive agreements. Consideration: whether cash consideration or Cash consideration, to be funded through share swap, and details of the same internal accruals. Particulars Details No Shares are to be acquired, only Cash Cost of acquisition and/ or the price at which consideration plus related expenses the shares are acquired (taxes, duties, stamp duty, registration and other incidental charges). Percentage of shareholding / control acquired Not applicable, as this is an acquisition of and/or number of shares acquired a plant/asset and not of shares/Control. Brief background about the entity acquired in Seller entity is not being acquired. terms of products/line of business acquired, However, its brief details are as follows: date of incorporation, history of last 3 years’ Axiom Chemicals Private Limited and is turnover, country in which the acquired entity engaged in business of Chemicals. The has presence and any other significant plant is engaged in manufacturing information (in brief) Chemicals.